Jordan Evans, MD
Dermatology · Davenport, IANPI 1629537576
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.7% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,231, more than ten times the $14 reported in 2022.
Across 153 payments — averaging $17.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$377
- Dermavant Sciences, Inc.$328
- UCB, Inc.$257
- Novartis$246
- E.r. Squibb & Sons, L.L.C.$200
- Pfizer$197
- plus $1K from 13 others
What the payments were for
- Food & beverage$2,42591%
- Education$2489%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $377 |
| Dermavant Sciences, Inc. | 27 | $328 |
| UCB, Inc. | 11 | $257 |
| Novartis | 11 | $246 |
| E.r. Squibb & Sons, L.L.C. | 10 | $200 |
| Pfizer | 19 | $197 |
| Johnson & Johnson | 6 | $187 |
| Incyte Corporation | 8 | $162 |
| Galderma Laboratories, L.p. | 4 | $129 |
| Regeneron Healthcare Solutions, Inc. | 5 | $121 |
| Sun Pharmaceutical Industries Inc. | 5 | $117 |
| Organon | 8 | $112 |
| Amgen | 4 | $65 |
| Fresenius Kabi USA, LLC | 2 | $56 |
| Lilly USA, LLC | 3 | $47 |
| Convatec Inc. | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $17 |
| Kerecis Limited | 1 | $13 |
How this compares
$2,672 in reported general payments places this provider in the 70th percentile of 92 dermatology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 30 | $115,373 |
| Tacrolimus | 54 | $5,946 |
| Clobetasol Propionate | 86 | $5,065 |
| Fluocinonide | 86 | $4,348 |
| Ketoconazole | 242 | $3,260 |
| Triamcinolone Acetonide | 228 | $2,769 |
| Fluorouracil | 35 | $2,707 |
| Doxycycline Monohydrate | 66 | $2,154 |
| Metronidazole | 37 | $1,883 |
| Clindamycin Phosphate | 46 | $1,497 |
| Fluocinolone Acetonide | 18 | $1,325 |
| Betamethasone Dipropionate | 19 | $902 |
| Hydrocortisone | 77 | $556 |
| Betamethasone Valerate | 15 | $553 |
| Hydroxychloroquine Sulfate | 12 | $525 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Davenport
- Ravindrakumar GangadhariahDavenport$20K
- Jill LightfootDavenport$3K
- William ColantoniDavenport$1K
- Roger CeilleyWest Des Moines$82K
- David KnutsonCedar Rapids$60K
- Scott GreenFort Dodge$56K
- Timothy AbrahamsonUrbandale$49K
- Ali JabbariIowa City$38K
- Somaira NowsheenWaukee$15K
- Laura MyersAnkeny$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.